Literature DB >> 2826811

Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro.

W J Weijer1, J W Drijfhout, H J Geerligs, W Bloemhoff, M Feijlbrief, C A Bos, P Hoogerhout, K E Kerling, T Popken-Boer, K Slopsema.   

Abstract

Peptides corresponding to residues 1-13, 9-21, 18-30, 82-93, 137-150, 181-197, 232-243, 235-243, 267-281, 271-281 and 302-315 of glycoprotein D of herpes simplex virus type 1 (HSV-1) were chemically synthesized. These peptides were coupled to carrier proteins, and the resulting conjugates were used to immunize rabbits. An enzyme-linked immunosorbent assay was used to determine antipeptide antibody titers in serum collected after immunization. All peptides appeared to be immunogenic in rabbits. Western immunoblot analysis with detergent extracts of HSV-1-infected Vero cells showed that antibodies against each of the peptides were able to react with the parent glycoprotein under denaturing conditions. Antisera against peptides 1-13, 9-21, and 18-30 neutralized HSV-1 infectivity in vitro, peptide 9-21 being the most successful in this respect. Immunization with a mixture of peptides 9-21 and 267-281 yielded antisera which reacted strongly with glycoprotein gD in Western blot analysis and showed a more solid virus-neutralizing activity in vitro.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2826811      PMCID: PMC250561          DOI: 10.1128/JVI.62.2.501-510.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Prediction of sequential antigenic regions in proteins.

Authors:  G W Welling; W J Weijer; R van der Zee; S Welling-Wester
Journal:  FEBS Lett       Date:  1985-09-02       Impact factor: 4.124

2.  1H-NMR assignment and secondary structure of a herpes simplex virus glycoprotein D-1 antigenic domain.

Authors:  M P Williamson; M J Hall; B K Handa
Journal:  Eur J Biochem       Date:  1986-08-01

3.  Structural properties and reactivity of N-terminal synthetic peptides of herpes simplex virus type 1 glycoprotein D by using antipeptide antibodies and group VII monoclonal antibodies.

Authors:  D L Bosch; H J Geerligs; W J Weijer; M Feijlbrief; G W Welling; S Welling-Wester
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein D.

Authors:  B Dietzschold; R J Eisenberg; M Ponce de Leon; E Golub; F Hudecz; A Varrichio; G H Cohen
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

6.  Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.

Authors:  G H Cohen; B Dietzschold; M Ponce de Leon; D Long; E Golub; A Varrichio; L Pereira; R J Eisenberg
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

7.  Antibodies that react with predetermined sites on proteins.

Authors:  J G Sutcliffe; T M Shinnick; N Green; R A Lerner
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

8.  Tapping the immunological repertoire to produce antibodies of predetermined specificity.

Authors:  R A Lerner
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

9.  Immunogenic structure of the influenza virus hemagglutinin.

Authors:  N Green; H Alexander; A Olson; S Alexander; T M Shinnick; J G Sutcliffe; R A Lerner
Journal:  Cell       Date:  1982-03       Impact factor: 41.582

10.  The amino-acid sequence of the three smallest CNBr peptides from p-hydroxybenzoate hydroxylase from Pseudomonas fluorescens.

Authors:  J M Vereijken; J Hofsteenge; H J Bak; J J Beintema
Journal:  Eur J Biochem       Date:  1980-12
View more
  13 in total

1.  Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodies.

Authors:  S Welling-Wester; M Feijlbrief; D G Koedijk; J W Drijfhout; W J Weijer; A J Scheffer; G W Welling
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

2.  Computer predictions of antigenic domains in herpes simplex virus types 1 and 2 glycoprotein D as compared with experimentally proven domains.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1991-10       Impact factor: 2.332

3.  Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein D.

Authors:  H J Geerligs; M Feijlbrief; M Bolk; C A Bos; J W Drijfhout; G W Welling; S Welling-Wester
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.

Authors:  V J Isola; R J Eisenberg; G R Siebert; C J Heilman; W C Wilcox; G H Cohen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Immunological properties of an N-terminal fragment of herpes simplex virus type 1 glycoprotein D expressed in Escherichia coli.

Authors:  C H Kocken; H J Geerligs; C A Bos; G Ab; W J Weijer; J W Drijfhout; G W Welling; S Welling-Wester
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Application of a transformed cell line constitutively expressing HSV-1 polypeptides for the detection of HSV antibodies in human sera by an enzyme immunoassay.

Authors:  A Sivropoulou; A Vasilaki; M Arsenakis
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B.

Authors:  J C Mester; S L Highlander; A P Osmand; J C Glorioso; B T Rouse
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines.

Authors:  K Brynestad; B Babbit; L Huang; B T Rouse
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  Identification of B-cell epitopes on the S4 subunit of pertussis toxin.

Authors:  P H Ibsen; A Holm; J W Petersen; C E Olsen; I Heron
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus.

Authors:  N C Strynadka; M J Redmond; J M Parker; D G Scraba; R S Hodges
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.